Flow cytometric minimal residual disease assessment in B‐cell precursor acute lymphoblastic leukaemia patients treated with CD19‐targeted therapies — a EuroFlow study-Reference-Cited by-同舟云学术

Flow cytometric minimal residual disease assessment in B‐cell precursor acute lymphoblastic leukaemia patients treated with CD19‐targeted therapies — a EuroFlow study

Published:2021-12-08 Issue: Volume: Page:
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Verbeek Martijn W. C.¹^ORCID,Buracchi Chiara²,Laqua Anna³,Nierkens Stefan⁴,Sedek Lukasz⁵⁶,Flores‐Montero Juan⁷⁸⁹¹⁰,Hofmans Mattias¹¹¹²,Sobral de Costa Elaine¹³,Nováková Michaela¹⁴,Mejstrikova Ester¹⁴^ORCID,Barrena Susana⁷⁸⁹¹⁰,Kohlscheen Saskia³,Szczepanowski Monika³,Kulis Jan⁵⁶,Oliveira Elen¹³,Jugooa Romana¹,Jong Anja X.⁴,Szczepanski Tomasz⁵⁶^ORCID,Philippé Jan¹¹¹²,Dongen Jacques J. M.¹⁵,Orfao Alberto⁷⁸⁹¹⁰^ORCID,Brüggemann Monika³,Gaipa Giuseppe²,Velden Vincent H. J.¹^ORCID

Affiliation:

1. Laboratory for Medical Immunology Department of Immunology Erasmus MC University Medical Center Rotterdam Rotterdam The Netherlands

2. Tettamanti Research Center Pediatric Clinic University of Milano Bicocca Monza (MB) Italy

3. Department of Hematology University of Schleswig‐Holstein, Campus Kiel Kiel Germany

4. Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands

5. Department of Microbiology and Immunology Medical University of Silesia in Katowice Zabrze Poland

6. Department of Pediatric Hematology and Oncology, Zabrze Medical University of Silesia in Katowice Katowice Poland

7. Translational and Clinical Research program Cancer Research Centre (IBMCC, CSIC‐USAL) Cytometry Service NUCLEUS Salamanca Spain

8. Department of Medicine University of Salamanca (USAL) Salamanca Spain

9. Institute of Biomedical Research of Salamanca (IBSAL) Salamanca Spain

10. Biomedical Research Networking Centre Consortium of Oncology (CIBERONC) Instituto de Salud Carlos III Madrid Spain

11. Department of Diagnostic Sciences Ghent University Ghent Belgium

12. Department of Laboratory Medicine Ghent University Hospital Ghent Belgium

13. Pediatrics Institute IPPMG Faculty of Medicine Federal University of Rio de Janeiro Rio de Janeiro Brazil

14. CLIP‐Department of Pediatric Hematology and Oncology Second Faculty of Medicine Charles University and University Hospital Motol Prague Czech Republic

15. Department of Immunohematology and Blood Transfusion (IHB) University Medical Center (LUMC) Leiden the Netherlands

Funder

European Commission

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17992

Reference13 articles.

1. Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies

2. Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting